Advertisement
Journal Home
Search for

Volume 205, Issue 1, Pages 279-283 (July 2009)


View previous. 47 of 56 View next.

Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women

E. Kassi, M. Dalamaga1, E. Faviou1, G. Hroussalas, K. Kazanis, Ch. Nounopoulos, A. Dionyssiou-AsteriouCorresponding Author Informationemail address

Received 19 May 2008; received in revised form 28 October 2008; accepted 9 November 2008. published online 25 December 2008.

Abstract 

Objective

The aim of the present study was to estimate circulating oxidized low-density lipoprotein (oxLDL) levels in postmenopausal women and evaluate their association with obesity and smoking status.

Design and methods

The study included 135 postmenopausal women aged 52–75 years. Forty of them were overweight (BMI 32.4±6.4) and non-smokers (Group A), 40 non-overweight (BMI 22.6±1.8) and smokers (Group B) and 55 non-overweight (BMI 23.5±1.4) and non-smokers (Group C). oxLDL and antibodies against them (anti-oxLDL) were measured using ELISA. Serum total cholesterol, LDL, HDL and triglycerides were measured in an automated analyzer.

Results

Total cholesterol, LDL, HDL and oxLDL serum levels were significantly elevated in Group A as compared to Group B or C, as well as oxLDL in Group B in comparison to Group C (p<0.001). Triglycerides and anti-oxLDL were increased in Group A in comparison to Group C (p=0.043 and 0.023). Total cholesterol, LDL, triglycerides and anti-oxLDL did not differ between Groups B and C, while HDL was decreased in Group B as compared to Group C (p<0.001). A significant positive correlation was found between oxLDL and LDL in Group A (r=0.53, p<0.001) as well as in Group C (r=0.955, p0.001) and a negative one between oxLDL and HDL in Group C (r=−0.933, p<0.001). Regression analysis revealed that obesity was a stronger predictor of LDL oxidation than smoking.

Conclusions

Postmenopausal obesity is involved in the process of LDL oxidation and appears to be a stronger predictor of LDL oxidation than smoking. Future studies are needed to confirm these associations.

Department of Biological Chemistry and Department of Clinical Biochemistry, Medical School, University of Athens, 11 Korinthou Str., 14564 Kifisia, Athens, Greece

Corresponding Author InformationCorresponding author. Tel.: +30 2108077255; fax: +30 2106201294.

1 These authors have contributed equally to this work.

PII: S0021-9150(08)00785-5

doi:10.1016/j.atherosclerosis.2008.11.006


View previous. 47 of 56 View next.

Advertisement